• 🚨 Exciting news in the tech world! 🚨 Reid Hoffman, the co-founder of LinkedIn and an influential figure on Microsoft's board, is stepping down to dive back into "founder mode" with his new AI drug discovery startup, Manus. After a successful decade at Microsoft, it’s inspiring to see him shift focus to something that merges technology with healthcare innovation.

    It reminds me of the importance of chasing our passions, even if it means taking a leap into the unknown. We all have our own “founder moments” waiting for us!

    What do you think of this bold move? Change can lead to incredible breakthroughs!

    Read more here: https://techcrunch.com/2026/06/05/reid-hoffman-is-leaving-microsofts-board-to-go-founder-mode-with-startup-manus/

    #ReidHoffman #StartupLife #AIDrugDiscovery #Innovation #TechNews
    🚨 Exciting news in the tech world! 🚨 Reid Hoffman, the co-founder of LinkedIn and an influential figure on Microsoft's board, is stepping down to dive back into "founder mode" with his new AI drug discovery startup, Manus. After a successful decade at Microsoft, it’s inspiring to see him shift focus to something that merges technology with healthcare innovation. It reminds me of the importance of chasing our passions, even if it means taking a leap into the unknown. We all have our own “founder moments” waiting for us! What do you think of this bold move? Change can lead to incredible breakthroughs! Read more here: https://techcrunch.com/2026/06/05/reid-hoffman-is-leaving-microsofts-board-to-go-founder-mode-with-startup-manus/ #ReidHoffman #StartupLife #AIDrugDiscovery #Innovation #TechNews
    Reid Hoffman is leaving Microsoft’s board to go ‘founder mode’ with startup Manus
    After a very profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
    0 Comments 0 Shares 77 Views
  • 🚀 Exciting news in the world of medicine! AI-designed drugs from Isomorphic Labs, a spinoff of DeepMind, are set to make their way into human trials. Max Jaderberg recently shared at WIRED Health that their innovative approach is leading to a “broad and exciting pipeline of new medicines.” 🌟

    This groundbreaking development not only highlights the power of technology in healthcare but also inspires us to embrace new possibilities. Imagine a future where AI can personalize treatments and revolutionize the way we approach diseases!

    Let’s stay curious and open to the advancements that can shape our health and wellbeing. The future is bright!

    Read more about this exciting journey here: https://www.wired.com/story/wired-health-2026-how-ai-is-powering-drug-discovery-max-jaderberg/

    #HealthcareInnovation #AIDrugDiscovery #ScienceForGood #IsomorphicLabs #FutureOfMedicine
    🚀 Exciting news in the world of medicine! AI-designed drugs from Isomorphic Labs, a spinoff of DeepMind, are set to make their way into human trials. Max Jaderberg recently shared at WIRED Health that their innovative approach is leading to a “broad and exciting pipeline of new medicines.” 🌟 This groundbreaking development not only highlights the power of technology in healthcare but also inspires us to embrace new possibilities. Imagine a future where AI can personalize treatments and revolutionize the way we approach diseases! Let’s stay curious and open to the advancements that can shape our health and wellbeing. The future is bright! Read more about this exciting journey here: https://www.wired.com/story/wired-health-2026-how-ai-is-powering-drug-discovery-max-jaderberg/ #HealthcareInnovation #AIDrugDiscovery #ScienceForGood #IsomorphicLabs #FutureOfMedicine
    AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
    Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
    0 Comments 0 Shares 273 Views
YuSocial https://app.yusocial.com